RESUMEN
Small cell carcinoma of the cervix (SCCC) is a rare histological entity of uterine cervical cancer. Compared with other common histological types, squamous cell carcinoma or adenocarcinoma, the outcome of SCCC is poor because of the high incidence of nodal or distant metastasis even with early stage. In this review, current consensus of epidemiology, pathology, and initial treatment for SCCC will be discussed.
Asunto(s)
Carcinoma de Células Pequeñas/patología , Oncología Médica , Guías de Práctica Clínica como Asunto , Neoplasias del Cuello Uterino/patología , Carcinoma de Células Pequeñas/terapia , Terapia Combinada , Consenso , Femenino , Humanos , Sociedades Médicas , Neoplasias del Cuello Uterino/terapiaRESUMEN
Small cell carcinomas of the ovary are uncommon and account for less than 1% of ovarian cancers. They were first recognized in 1979, and a number of reports appeared during the next 2 decades. They are highly aggressive tumors and usually carry a poor prognosis, although this may reflect that most are diagnosed at advanced stage; however, those diagnosed as stage 1A have only 30% to 40% of long-term survivors. More reports followed extending our experience in the diagnosis and management of these rare cancers. The classification is described below and shown in Table 1, but a revision is expected to be published from the World Health Organization in 2014.